| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/20/2012 | CN102504024A Antibodies that bind human interleukin-18 and methods of making and using |
| 06/20/2012 | CN102504018A Melittin pamoate capable of being continuously released and preparation agent thereof |
| 06/20/2012 | CN102504013A Target chemical drug PADM against cancer metastasis and preparation method and use thereof |
| 06/20/2012 | CN102504006A Steroid saponin compound in siberian fritillary bulb |
| 06/20/2012 | CN102504005A Compound with novel structure and preparation method and applications thereof |
| 06/20/2012 | CN102503995A Glycosilated 4,4'-dimethylxanthotoxin derivative and use thereof |
| 06/20/2012 | CN102503987A Compound with anti-tumor activity as well as preparation method and purpose thereof |
| 06/20/2012 | CN102503984A Platinum-based complex for anti-cancer medicament and preparation method thereof |
| 06/20/2012 | CN102503976A Alpha-quaternary carbon contained alpha, beta-diamino acid derivative, synthetic method thereof and application thereof |
| 06/20/2012 | CN102503959A Tricyclic compounds and preparation method thereof, and medicinal composition containing compounds and application thereof |
| 06/20/2012 | CN102503951A Garcinia derivative and preparation method and medicinal application thereof |
| 06/20/2012 | CN102503947A Photosensitizer chlorin e6 titanium compound for treating tumors by photo-oxygen dynamic and preparation method thereof |
| 06/20/2012 | CN102503945A Compound capable of inhibiting epidermal growth factor receptor and application thereof |
| 06/20/2012 | CN102503930A 3, 4, 5-tri-substituted aminothiopene chemical compound and preparation and application thereof |
| 06/20/2012 | CN102503908A Vitamin A acid derivative, preparation method thereof, medicine composition thereof and application thereof to preparation anti-tumor medicine |
| 06/20/2012 | CN102503899A Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 06/20/2012 | CN102503897A 5-fluorouracil iodized oil derivative as well as preparation method and application thereof |
| 06/20/2012 | CN102503892A Co-containing sandwich heteropolyacid as well as synthesis method and application thereof |
| 06/20/2012 | CN102503888A 2-aryl-1,3-isoquinoline diketone anti-tumor compound and synthesis method and application thereof |
| 06/20/2012 | CN102503882A Halogenated benzaldehyde indole Schiff base as well as preparation method and application thereof |
| 06/20/2012 | CN102503881A Optically active tryptamine derivative and synthetic method and application thereof |
| 06/20/2012 | CN102503869A 2-Hydroxylimine hydrocinnamamide ethanedithiol derivatives and application thereof |
| 06/20/2012 | CN102503857A Bexarotene hydroximic acid as well as preparation method and application thereof |
| 06/20/2012 | CN102503842A Curcumin derivative as well as preparation method and usage thereof |
| 06/20/2012 | CN102503826A Compound Blapsins A and B, pharmaceutical composition containing the same, and preparation method and application thereof |
| 06/20/2012 | CN102499986A Macromolecule-cis-platinum compound, preparation method and application thereof |
| 06/20/2012 | CN102499953A Process for extracting total phenyl propanoid from paulownia bark of paulownia tomentosa (original variety) by adopting supercritical CO2 fluid technology |
| 06/20/2012 | CN102499948A Preparation method of Ainsliaea lactone substances |
| 06/20/2012 | CN102499943A Preparation and anti-tumor activity of polymer wrapped heteropoly acid nano hybrid material |
| 06/20/2012 | CN102499942A Application of combined utilization of triptolide cisplatin in preparation of pancreatic cancer drug against drug resistance |
| 06/20/2012 | CN102499938A Agonist and application of Toll-like receptors 7 and 8 |
| 06/20/2012 | CN102499937A Application of the combination of deoxynucleosides and nucleosides in preparation of antitumor drugs |
| 06/20/2012 | CN102499931A New application of disaccharide compound |
| 06/20/2012 | CN102499929A 42-(Dimethylphosphinate)rapamycin solid composition and coating method thereof |
| 06/20/2012 | CN102499927A Medicine composition for preventing and curing tumors |
| 06/20/2012 | CN102499905A Controllable photoresponse type hydrophobic medicament carrier hydrogel and preparation method thereof |
| 06/20/2012 | CN102114116B Traditional Chinese medicine for treating esophageal carcinoma |
| 06/20/2012 | CN102070573B Mono-tetrahydrofuran type sugar apple lactone compound with anti-tumor activity and application thereof |
| 06/20/2012 | CN102020623B Butterbur extract as well as preparation method and application thereof |
| 06/20/2012 | CN102008444B Preparation method of mitoxantrone-loaded dextran-polylactic acid copolymer nano particles |
| 06/20/2012 | CN101972448B Chinese medicinal composition for treating liver cancer |
| 06/20/2012 | CN101972431B Medicinal composition for inhibiting angiogenesis in breast cancer cells and preparation method thereof |
| 06/20/2012 | CN101939001B Combination comprising paclitaxel for treating ovarian cancer |
| 06/20/2012 | CN101919875B Preparation method of enteromorpha mushroom polysaccharide compound |
| 06/20/2012 | CN101892255B Recombinant vector for regulating expression of two target genes by using promoter |
| 06/20/2012 | CN101870734B Fusogenic polypeptide for inhibiting neovascularization and coding gene and application thereof |
| 06/20/2012 | CN101849909B Preparation method of magnetic disodium clodronate liposome |
| 06/20/2012 | CN101829080B Application of iridoid compound to preparation of ovarian cancer resistance medicament |
| 06/20/2012 | CN101810570B Lipid nano particle preparation containing composite formed fatty acid and anthracyclines antitumor antibiotics and preparation method thereof |
| 06/20/2012 | CN101787025B Substituted-evodiamine anti-tumor and antifungal compounds and preparation method thereof |
| 06/20/2012 | CN101768576B HSV1-TK (herpes simplex virus type 1-thymidine kinase) gene recombination oncolytic adenovirus, preparation method and application thereof |
| 06/20/2012 | CN101717373B Diaryl urea derivative and application thereof |
| 06/20/2012 | CN101670010B Method for extracting flavonoid glycoside substance |
| 06/20/2012 | CN101602808B Specific binding protein and application thereof |
| 06/20/2012 | CN101518556B Polysaccharide with antitumor and immunologic adjuvant function as well as preparation method and purpose thereof |
| 06/20/2012 | CN101491495B Salvianolic acid B magnesium injection, preparation method and use thereof |
| 06/20/2012 | CN101461793B Method for preparing beta-elemene lipidosome and freeze-dried powder |
| 06/20/2012 | CN101362702B Emodin derivates and application thereof in anti-cancer medicine preparation |
| 06/20/2012 | CN101268085B Boron compounds useful in BNCT |
| 06/20/2012 | CN101112373B Methods of administering epothilone analogs for the treatment of cancer |
| 06/20/2012 | CN101072793B Il-7 variants with reduced immunogenicity |
| 06/19/2012 | US8202980 Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 06/19/2012 | US8202911 Migrastatin analog compositions and uses thereof |
| 06/19/2012 | US8202867 Methods of using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide |
| 06/19/2012 | US8202860 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS) |
| 06/19/2012 | US8202724 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 06/19/2012 | US8202696 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated PP2Ac |
| 06/19/2012 | US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/19/2012 | CA2684169C Smac mimetic dimers and trimers useful as anti-cancer agents |
| 06/19/2012 | CA2599754C Use of interleukin 17e for the treatment of cancer |
| 06/19/2012 | CA2559302C 6-amino-1h-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors |
| 06/19/2012 | CA2491943C Epothilone derivatives for the treatment of cancer |
| 06/19/2012 | CA2478012C Internalizing anti-cd74 antibodies and methods of use |
| 06/19/2012 | CA2422538C Notch receptor agonists and uses |
| 06/19/2012 | CA2406169C Polyamide nucleic acid derivatives, and agents and processes for preparing them |
| 06/19/2012 | CA2390898C Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 06/19/2012 | CA2349202C Method of preparing stable suspensions of insoluble microparticles |
| 06/19/2012 | CA2319872C Pharmaceutical composition for the treatment of hepatocellular carcinoma |
| 06/14/2012 | WO2012079088A2 Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases |
| 06/14/2012 | WO2012079075A1 Deuterated phthalimide derivatives |
| 06/14/2012 | WO2012078859A2 Protein kinase d inhibitors |
| 06/14/2012 | WO2012078832A1 Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer |
| 06/14/2012 | WO2012078831A2 Smart polymeric nanoparticles which overcome multidrug resistance to cancer chemotherapeutics and treatment-related systemic toxicity |
| 06/14/2012 | WO2012078771A1 Treatment of her2-positive cancer with paclitaxel and trastuzumab-mcc-dm1 |
| 06/14/2012 | WO2012078757A2 Combination breast cancer therapy with hsp90 inhibitory compounds |
| 06/14/2012 | WO2012078746A2 Compositions and methods for mobilizing stem cells |
| 06/14/2012 | WO2012078695A2 Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracyclin chemotherapeutic agents |
| 06/14/2012 | WO2012078667A2 Compositions and methods relating to proliferative diseases |
| 06/14/2012 | WO2012078633A2 Methods of inhibiting metastasis from cancer |
| 06/14/2012 | WO2012078586A2 Pharmaceutical composition comprising nanog shrna, and method of usnig nanog shrna to treat cancer |
| 06/14/2012 | WO2012078534A1 Psma-targeted dendrimers |
| 06/14/2012 | WO2012078492A1 A combination therapy with lenalidomide and a cdk inhibitor for treating multiple myeloma |
| 06/14/2012 | WO2012077811A1 Galectin 9-secreting cell, production method for same, and application for same |
| 06/14/2012 | WO2012077649A1 Human monoclonal antibody |
| 06/14/2012 | WO2012076942A1 4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof |
| 06/14/2012 | WO2012076898A1 Triazole derivatives as wnt signaling pathway inhibitors |
| 06/14/2012 | WO2012076897A1 Disulfiram formulation and uses thereof |
| 06/14/2012 | WO2012076883A1 Anti ccr4 antibodies and uses thereof |
| 06/14/2012 | WO2012076842A1 Synthetic retinoids for control of cell differentiation |
| 06/14/2012 | WO2012076824A1 Novel derivatives of oxazaphosphorines that are pre-activated, use and method of preparation |